High‐Throughput Viral Integration Detection Reveals Baseline Breakpoints Burden Associated With HBsAg Seroclearance
Alimentary Pharmacology & Therapeutics2025Vol. 62(9), pp. 887–900
Citations Over TimeTop 10% of 2025 papers
M. H. Gu, Wenyu Wu, Jie You, Qianjun Wu, Fei Huang, Yixuan Zhang, Peng Wang, Dong Xi, Weiming Yan, Xiaojing Wang, Tao Chen, Di Wu, Qin Ning, Meifang Han
Abstract
The Anchor study is registered at ClinicalTrials.gov, NCT02327416.
Related Papers
- → Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment(2022)65 cited
- → An Ideal Hallmark Closest to Complete Cure of Chronic Hepatitis B Patients: High-sensitivity Quantitative HBsAg Loss(2022)14 cited
- 구연 : HBsAg이 소실된 환자의 간조직내 B형 간염 바이러스 염기서열 분석 및 임상적 의의(2003)
- Inhibitory effect of FFYC tablets(FFYC) on expression of HBsAg and HBeAg(2004)
- → HBsAg kinetics during and after nucleos(t)ide analogues described by mathematical modeling(2023)